Regulation And Legal
Symbiox Investment Confirms No Fundraising in Q2 FY2027
• Symbiox Investment submitted a regulatory compliance letter to BSE, CSE, and MSEI.
• The company confirmed it raised no funds via public, rights, or preferential issues in Q2 FY2027.
• Consequently,
